Who are the Market Top Companies and What are Their Offerings?
| Companies | Headquarters | UK AI in Life Science Solutions |
| Isomorphic Labs | London, UK | AlphaFold 3 Architecture/Next-Gen Drug Design Engine |
| Lifebit | London, UK | Federated AI Platform and Lifebit CloudOS |
| Exscientia | Oxford, UK | Patient-First AI Platform and Centaur Biologist |
| Latent Labs | London, UK | Simon |
| BenevolentAI | London, UK | Benevolent Platform |
| Owkin | London, UK | MOSAIC/Federated Learning Network |
| Healx | Cambridge, UK | HealNet |
| Optibrium | Cambridge, UK | Cerella/StarDrop |
| Causaly | London, UK | Causaly Cloud Enterprise Platform |
| CHARM Therapeutics | London, UK | DragonFold |
What are the Major Recent Developments in the Market?
- In May 2026, a new AI-enabled capability for Mosaic was launched by Cenevo, which enables connected labs for life sciences with its agentic lab platform. With the use of natural language, the new platform Mosaic AI Inventory Search will support the scientists in faster and more intuitive sample discovery.
- In May 2026, Flatiron Telescope, which is a next-generation AI-powered platform, was launched by Flatiron Health. This platform will help the life sciences teams and researchers in assessing study feasibility in real time, searching for the right patients, and creating oncology insights.
Market Growth
The UK AI in life science market size was estimated at USD 210 million in 2025 and is predicted to increase from USD 249.9 million in 2026 to approximately USD 1195.88 million by 2035, expanding at a CAGR of 19% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking